FidlerHKBoyesDALochDR. The cytology programme in British Columbia. Can Med Assoc J1962; 86:823–825.
2.
YoungPAHertigATArmstrongD. A study of 135 cases of carcinoma in situ of the cervix at the Free Hospital for Women, Am J Obstet Gynecol1949; 58:867–869.
3.
JonesJMSweetmanPHibbardBM. The outcome of pregnancy after cone biopsy of the cervix: A case-control study. Br J Obstet Gynaecol1979; 86:913–916.
4.
KirkupWSingerA. Colposcopy in the management of the pregnant patient with abnormal cervical cytology. Br J Obstet Gynaecol1980; 87:322–325.
5.
AndersonMCHartleyRB. Cervical crypt involvement by intraepithelial neoplasia. Obstet Gynecol1980; 55:546–550.
6.
DuncanID. Treatment of CIN by destruction with the Semm ‘Cold’ Coagulator. In JordanJASharpFSingerA, eds. Preclinical Neoplasia of the Cervix. London: Proc Study Group, RCOG1982.
7.
TownsendDERichartRMMarksENeilsenJ. Invasive cancer following outpatient evaluation and therapy for cervical disease. Obstet Gynecol1981; 57:145–149.
8.
NialsZMNahmiasAJJoseyWE. Cytology and histopathology of cervical herpes simples infection. Cancer1966; 19:1026–1028.
9.
MieselsAFortinRRoyM. Condylomatous lesions of the cervix II: Cytologic, colposcopic and histopathologic study. Acta Cytol1977; 21:379–390.
10.
HareMJ. Is chlamydia a factor? IN JordanJASharpFSingerA, eds. Preclinical Neoplasia of the Cervix. London: Proc Study Group, RCOG1982.
11.
ReidBL. The behaviour of human sperm towards cultured fragments of human cervix uteri. Lancet1964; 1:21–23.
12.
SkeggDCGCorwinPAPaulCDollR. Importance of the male factor in cancer of the cervix. Lancet1982; 2:581–583.
13.
SingerAWalkerP. What is the optimum treatment of cervical premalignancy?Br J Obstet Gynaecol1982; 89:335–337.
14.
BevanJRAttwoodMBLucasANewtonJR. Treatment of pre-invasive disease of the cervix by cone biopsy. Br J Obstet Gynaecol1981; 88:1140–1144.
